Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants
Autor: | Cyril Desevaux, Luc Chouinard, Louis Huneault, Pascal Dubreuil, Bertrand Lussier |
---|---|
Rok vydání: | 2004 |
Předmět: |
Male
medicine.medical_specialty Microbiological culture Periosteal reaction Dentistry Bone healing medicine.disease_cause Dogs Anti-Infective Agents Ciprofloxacin Absorbable Implants medicine Animals Orthopedics and Sports Medicine Femur business.industry Osteomyelitis medicine.disease Surgery Radiography Disease Models Animal Cross-Linking Reagents Staphylococcus aureus Female Amylose Implant business medicine.drug |
Zdroj: | Journal of Orthopaedic Research. 22:1351-1357 |
ISSN: | 1554-527X 0736-0266 |
DOI: | 10.1016/j.orthres.2004.04.007 |
Popis: | Crosslinked high amylose starch (CLHAS) matrix was used as a biodegradable drug delivery implant for the prevention and treatment of osteomyelitis. Thirty-two dogs underwent the femoral insertion of a screw inoculated with Staphylococcus aureus and were then randomly assigned to four groups: (A) prevention with ciprofloxacin-CLHAS implants, (B) surgical debridement (positive control), (C) surgical debridement and oral ciprofloxacin treatment and (D) surgical debridement and treatment with ciprofloxacin-CLHAS implants. At week 4 the osteomyelitis was confirmed, the infected site debrided and respective treatments initiated for groups B, C and D. Radiographs, macroscopic evaluations, bacterial cultures and histopathological examinations were used to evaluate the femora at week 10. Femora from preventive group A were almost normal. Dogs of both ciprofloxacin treatment groups C and D showed better bone healing, less periosteal reaction and less screw mobility than dogs from group B. Eradication of infection was observed at proximal/distal sites in B: 25%/12%, C: 37%/62% and D: 62%/75%. Both ciprofloxacin treated groups improved radiographically from week 4 to week 10. Periosteal and marrow neutrophilic and lymphoplasmocytic infiltrations were less severe in groups C and D versus group B. These data suggest that biodegradable ciprofloxacin-CLHAS implants are a safe and efficient modality for the prevention and treatment of osteomyelitis. |
Databáze: | OpenAIRE |
Externí odkaz: |